Hmm, maybe I should skip to that one then.
What drove you off LAbN if I may ask?
What drove you off LAbN if I may ask?
December 11, 2025 at 3:19 AM
Hmm, maybe I should skip to that one then.
What drove you off LAbN if I may ask?
What drove you off LAbN if I may ask?
LABN Trending: The Los Angeles Sports & Entertainment Commission (LASEC) Names Amgen as Official Biotech Partner and Los Angeles World Cup 2026 Host City Supporter Ahead of FIFA World Cup 2026™ https://zpr.io/MKAWq5j4QHNb
December 7, 2025 at 3:13 AM
LABN Trending: The Los Angeles Sports & Entertainment Commission (LASEC) Names Amgen as Official Biotech Partner and Los Angeles World Cup 2026 Host City Supporter Ahead of FIFA World Cup 2026™ https://zpr.io/MKAWq5j4QHNb
LABN Trending: UCLA scientists develop one-product-fits-all immunotherapy for pancreatic cancer https://zpr.io/qjExKTjqvMmm
November 27, 2025 at 12:18 AM
LABN Trending: UCLA scientists develop one-product-fits-all immunotherapy for pancreatic cancer https://zpr.io/qjExKTjqvMmm
LABN Trending: Abbott’s $21B diagnostic deal; Job cuts at Applied Therapeutics and AbbVie https://zpr.io/XLFgtNuzKZar
November 21, 2025 at 12:57 AM
LABN Trending: Abbott’s $21B diagnostic deal; Job cuts at Applied Therapeutics and AbbVie https://zpr.io/XLFgtNuzKZar
LABN Trending: Ben Stiller, Martin Short, Christine Taylor, Michael Shannon, and Cast Members of “Love on The Spectrum” Headline Holiday Classic: “It’s a Wonderful Life” Table Read Benefiting The Ed Asner Family Center & Families with Special Needs https://zpr.io/QDsNpanhMKmE
November 17, 2025 at 7:18 PM
LABN Trending: Ben Stiller, Martin Short, Christine Taylor, Michael Shannon, and Cast Members of “Love on The Spectrum” Headline Holiday Classic: “It’s a Wonderful Life” Table Read Benefiting The Ed Asner Family Center & Families with Special Needs https://zpr.io/QDsNpanhMKmE
DAS ist kein Läbn.
Couscous, Bulgur, Dinkel, Linsen, Bohnen, Erbsen etc..
Couscous, Bulgur, Dinkel, Linsen, Bohnen, Erbsen etc..
November 1, 2025 at 5:41 AM
DAS ist kein Läbn.
Couscous, Bulgur, Dinkel, Linsen, Bohnen, Erbsen etc..
Couscous, Bulgur, Dinkel, Linsen, Bohnen, Erbsen etc..
LABN Trending: Breakthrough Genomics Showcases Largest Interpreted Literature Database and Unveils New AI Capabilities at ASHG 2025 https://zpr.io/GX5R5L9gxmuF
October 22, 2025 at 11:48 AM
LABN Trending: Breakthrough Genomics Showcases Largest Interpreted Literature Database and Unveils New AI Capabilities at ASHG 2025 https://zpr.io/GX5R5L9gxmuF
LABN Trending: Celcuity’s shares rally after ESMO readouts; Disc Medicine’s $220M stock sale https://zpr.io/WNeJTEBX4vqy
October 21, 2025 at 3:38 AM
LABN Trending: Celcuity’s shares rally after ESMO readouts; Disc Medicine’s $220M stock sale https://zpr.io/WNeJTEBX4vqy
LABN Trending: Amgen, AZ’s Tezspire gains 2nd FDA nod, upping the ante in its battle with Dupixent https://zpr.io/gRhpmpKZHc9p
October 21, 2025 at 12:29 AM
LABN Trending: Amgen, AZ’s Tezspire gains 2nd FDA nod, upping the ante in its battle with Dupixent https://zpr.io/gRhpmpKZHc9p
LABN Trending: #ESMO25: Amgen, Zai Lab detail reduced survival benefit in stomach cancer trial https://zpr.io/bv8TZLJPRQt5
October 20, 2025 at 6:38 AM
LABN Trending: #ESMO25: Amgen, Zai Lab detail reduced survival benefit in stomach cancer trial https://zpr.io/bv8TZLJPRQt5
LABN Trending: Adagio Medical Unveils Preliminary Acute Results from FULCRUM-VT U.S. Pivotal Study in Late Breaking Session at VT Symposium https://zpr.io/fEjkLEbLfyDa
October 12, 2025 at 12:48 AM
LABN Trending: Adagio Medical Unveils Preliminary Acute Results from FULCRUM-VT U.S. Pivotal Study in Late Breaking Session at VT Symposium https://zpr.io/fEjkLEbLfyDa
LABN Trending: HOMEBOY INDUSTRIES PARTNERS WITH FRANK MCCOURT TO ANNOUNCE $100 MILLION FUNDRAISING CAMPAIGN https://zpr.io/ge3NtFc87UdX
October 11, 2025 at 12:58 PM
LABN Trending: HOMEBOY INDUSTRIES PARTNERS WITH FRANK MCCOURT TO ANNOUNCE $100 MILLION FUNDRAISING CAMPAIGN https://zpr.io/ge3NtFc87UdX
LABN Trending: Algae-Based Gel Offers New Tool for Breast Cancer Research https://zpr.io/2mcfraaKkyjr
October 3, 2025 at 10:59 PM
LABN Trending: Algae-Based Gel Offers New Tool for Breast Cancer Research https://zpr.io/2mcfraaKkyjr
LABN Trending: Amgen charts late-stage win for Repatha in broad cardiovascular risk population https://zpr.io/MxFTrarxCpS9
October 3, 2025 at 7:40 PM
LABN Trending: Amgen charts late-stage win for Repatha in broad cardiovascular risk population https://zpr.io/MxFTrarxCpS9
LABN Trending: Amgen’s cholesterol-lowering shot could get sales boost from CV trial success https://zpr.io/vv9zz4ybuU6x
October 2, 2025 at 5:27 PM
LABN Trending: Amgen’s cholesterol-lowering shot could get sales boost from CV trial success https://zpr.io/vv9zz4ybuU6x
LABN Trending: More Unhoused Seniors in Los Angeles County will Find a Home and Access Healthcare Thanks to a $7 Million Partnership with Health Net and Centene Foundation https://zpr.io/4JkxFUEpMnqW
October 2, 2025 at 2:20 PM
LABN Trending: More Unhoused Seniors in Los Angeles County will Find a Home and Access Healthcare Thanks to a $7 Million Partnership with Health Net and Centene Foundation https://zpr.io/4JkxFUEpMnqW
LABN Trending: The Silent Epidemic of Aging: How Technology is Restoring Connection for Millions https://zpr.io/Jc8GDPV9v4We
October 1, 2025 at 4:49 AM
LABN Trending: The Silent Epidemic of Aging: How Technology is Restoring Connection for Millions https://zpr.io/Jc8GDPV9v4We
LABN Trending: Gut Health Gets an Upgrade: Good Bacteria Launches First Rotating Synbiotic to Rewild the Gut https://zpr.io/WCXBeYQnrkHV
October 1, 2025 at 12:18 AM
LABN Trending: Gut Health Gets an Upgrade: Good Bacteria Launches First Rotating Synbiotic to Rewild the Gut https://zpr.io/WCXBeYQnrkHV
LABN Trending: AMGEN ANNOUNCES $650M EXPANSION OF U.S. MANUFACTURING, CREATING HUNDREDS OF NEW JOBS https://zpr.io/GS47KrWbSiEd
September 27, 2025 at 5:48 AM
LABN Trending: AMGEN ANNOUNCES $650M EXPANSION OF U.S. MANUFACTURING, CREATING HUNDREDS OF NEW JOBS https://zpr.io/GS47KrWbSiEd
LABN Trending: Pan-Cancer Immunotherapy Avoids Healthy Tissue by Targeting Glycans https://zpr.io/RnPTjyjtPSMu
September 27, 2025 at 12:07 AM
LABN Trending: Pan-Cancer Immunotherapy Avoids Healthy Tissue by Targeting Glycans https://zpr.io/RnPTjyjtPSMu
LABN Trending: Glaukos Breaks Ground on New Research, Development, and Manufacturing Facility in Huntsville, Alabama https://zpr.io/kvSMVfPbnSpB
September 26, 2025 at 2:19 PM
LABN Trending: Glaukos Breaks Ground on New Research, Development, and Manufacturing Facility in Huntsville, Alabama https://zpr.io/kvSMVfPbnSpB
LABN Trending: TAE Life Sciences and University of Wisconsin-Madison to Bring Promising Accelerator-Based BNCT Cancer Treatment to the USA https://zpr.io/pkR99MREahmG
September 25, 2025 at 7:41 PM
LABN Trending: TAE Life Sciences and University of Wisconsin-Madison to Bring Promising Accelerator-Based BNCT Cancer Treatment to the USA https://zpr.io/pkR99MREahmG
LABN Trending: Angelalign Technologies Remains Confident in Light of its Competitor’s New Complaint and Diversion Tactic https://zpr.io/CMnb2h8Ckq25
September 25, 2025 at 6:28 AM
LABN Trending: Angelalign Technologies Remains Confident in Light of its Competitor’s New Complaint and Diversion Tactic https://zpr.io/CMnb2h8Ckq25
LABN Trending: Partillion’s Nanovials Power Breakthrough Cell-Cell Interaction Mapping, Driving Call for Billion Cell × Cell Project https://zpr.io/yGsLHuKCVEc8
September 23, 2025 at 2:49 PM
LABN Trending: Partillion’s Nanovials Power Breakthrough Cell-Cell Interaction Mapping, Driving Call for Billion Cell × Cell Project https://zpr.io/yGsLHuKCVEc8
Un nouveau rapport a révélé que les chatbots d'IA, y compris les modèles d'OpenAI et de Meta, contiennent de fausses informations dans une réponse sur trois.
➡️ https://l.euronews.com/LaBn
➡️ https://l.euronews.com/LaBn
September 20, 2025 at 5:09 PM
Un nouveau rapport a révélé que les chatbots d'IA, y compris les modèles d'OpenAI et de Meta, contiennent de fausses informations dans une réponse sur trois.
➡️ https://l.euronews.com/LaBn
➡️ https://l.euronews.com/LaBn